Rovadicitinib

rovadicitinib · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rovadicitinib, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease [Phase 3]

See pricing